Our results demonstrated that h-Prune levels were significantly higher in the lung cancer patients, and even more interesting in patients with early stages of NSCLC, than in the healthy controls (P< 0.0005; Fig. 5b-c). The gene discussed is PRUNE1; the disease is lung cancer.